A systematic review of clinical practice guidelines on the use of low molecular weight heparin and fondaparinux for the treatment and prevention of venous thromboembolism: Implications for research and policy decision-making

BACKGROUND: Venous thromboembolism (VTE) is a major global cause of morbidity and mortality. Low molecular weight heparin (LMWH) and fondaparinux (FDP) are frequently used to treat and prevent VTE and have a variety of safety and practical advantages over other anticoagulants, including use in outpa...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnston, Amy, Hsieh, Shu-Ching, Carrier, Marc, Kelly, Shannon E., Bai, Zemin, Skidmore, Becky, Wells, George A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226206/
https://www.ncbi.nlm.nih.gov/pubmed/30412622
http://dx.doi.org/10.1371/journal.pone.0207410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226206/
https://www.ncbi.nlm.nih.gov/pubmed/30412622
http://dx.doi.org/10.1371/journal.pone.0207410

Ejemplares similares